Pathology of mucopolysaccharidosis IIIA in huntaway dogs

Veterinary Pathology

Volumn 44, Issue 5, 2007, Pages 569-578

  Jolly, Robert D ^a   Johnstone, A C ^a   Norman, E J ^a   Hopwood, J J ^c   Walkley, S U ^b  

^a MASSEY UNIVERSITY   (New Zealand)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Dog diseases; Gangliosides; Heparan sulfate proteoglycans; Histopathology; Macrophages; Mucopolysaccharidosis IIIA; Nervous system diseases

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; BRAIN CORTEX; CEREBELLUM; DOG; DOG DISEASE; KIDNEY; LIVER; PATHOLOGY; SANFILIPPO SYNDROME; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; CEREBELLUM; CEREBRAL CORTEX; DOG DISEASES; DOGS; KIDNEY; LIVER; MICROSCOPY, ELECTRON, TRANSMISSION; MUCOPOLYSACCHARIDOSIS III;

CANIS FAMILIARIS;

EID: 34548848254     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1354/vp.44-5-569     Document Type: Article

References (31)

1. Aronovich EL, Carmichael KP, Morizono H, Koutlas IG, Deanching M, Hoganson G, Fischer A, Whitley CB: Canine heparan sulfate sulfamidase and the molecular pathology underlying Sanfilippo syndrome type A in Dachshunds. Genomics 68:80-84, 2000
2. Avila JL, Convit J: Inhibition of leucocytic lysosomal enzymes by glycosaminoglycans in vitro. Biochem J 152:57-64, 1975
3. L-glutamate and its receptors in rat Purkinje cells. J Comp Neurol 402:252-263, 1998
4. Bayliss High OB, Lake BD: Lipids. In: The Theory and Practice of Histological Techniques, ed. Bancroft JD and Stevens A, pp. 213-242. Churchill Livingstone, New York, NY, USA, 1996
5. Bernfield M, Götte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, Zako M: Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68:729-777, 1999
6. Bhaumik M, Muller VJ, Rozaklis T, Johnson L, Dobrenis K, Bhattacharryya R, Wurzelmann S, Finamore P, Hopwood JJ, Walkley SU, Stanley PA: A mouse model of mucopolysaccharidosis IIIA (Sanfilippo syndrome). Glycobiol 9:1389-1396, 1999
7. Cook HC: Carbohydrates. In: The Theory and Practice of Histological Techniques, ed. Bancroft JD and Stevens A, pp. 173-211. Churchill Livingstone, New York, NY, USA, 1996
8. Fischer A, Carmichael KP, Munnell JF, Jhabvala P, Thompson JN, Matalon R, Jezyk PF, Wang P, Giger U: Sulfamidase deficiency in a family of Dachshunds: a model of mucopolysaccharidosis IIIA (Sanfilippo A). Pediatr Res 44:74-82, 1998
9. Ikemoto T, Yorifuji H, Satoh T, Visi ES: Reversibility of cisternal stack formation during hypoxic hypoxia and subsequent reoxygenation in cerebellar Purkinje cells. Neurochem Res 28:1535-1542, 2003
10. M2 gangliosidosis. Brain 126:974-998, 2003
11. Jolly RD, Allan FJ, Collett MG, Rozalis T, Muller VJ, Hopwood JJ: Mucopolysaccharidosis IIIA (Sanfilippo syndrome) in a New Zealand Huntaway dog with ataxia. NZ Vet J 48:144-148, 2000
12. Jolly RD, Ehrlich PC, Franklin RJM, MacDougal DF, Palmer AC: Histological diagnosis of mucopolysaccharidosis IIIA in a Wire-haired Dachshund. Vet Rec 148:564-567, 2001
13. Jolly RD, Thompson KG, Van de Water NS, Winchester BG, Walkley SU, Daniel PF: Bovine mannosidosis. In: Swainsonine and Related Glycosidase Inhibitors, ed. James LF, Elbien AD, Molyneux RJ, and Warren CD, pp. 291-303. Iowa State University Press, Ames, IA, USA, 1989
14. Kay GW, Palmer DN, Rezaie P, Cooper JD: Activation of non-neuronal cells within the prenatal developing brain of sheep with ceroid-lipofuscinosis. Brain Pathol 16:110-116, 2006
15. Macheleidt O, Kolter T, Sandhoff K: Defects in activator proteins and other soluble proteins of the lysosome. In: Lysosomal Disorders of the Brain, ed. Platt FM and Walkley SU, pp. 186-205. Oxford University Press, Oxford, UK, 2004
16. McGlynn R, Dobrenis K, Walkley SU: Differential subcellular localization of cholesterol, gangliosides and glycosaminoglycans in murine models of mucopolysaccharide storage disorders. J Comp Neurol 480:415-426, 2004
17. Neufeld EF, Muezner J: The mucopolysaccharidoses In: The Metabolic and Molecular Bases of Inherited Disease, 8th ed., vol III, ed. Scriver R, Beaudet AL, Sly WS, and Valle D, pp. 3421-3452. McGraw-Hill, New York, NY, USA, 2001
18. Ohmi K, Greenberg DS, Rajavel KS, Ryazantsev S, Li HH, Neufeld EF: Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB. Proc Natl Acad Sci USA 100:1902-1907, 2003
19. Oswald MJ, Palmer DN, Kay GW, Shemilt SJA, Rezaie P, Cooper JD: Glial activation spreads from specific cerebral foci and precedes neurodegeneration in presymptomatic ovine neuronal ceroid lipofuscinosis (CLN6). Neurobiol Dis 20:49-65, 2005
20. Wada R, Tifft CJ, Proia RL: Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation. Proc Natl Acad Sci USA 97:10954-10959, 2000
21. Walkley SU: Pathogenic cascades and brain dysfunction, In: Lysosomal Disorders of the Brain, ed. Platt FM and Walkley SU, pp. 29-324. Oxford University Press, Oxford, UK, 2004
22. Walkley SU: Secondary accumulation of gangliosides in lysosomal storage disorders. Semin Cell Biol Develop 15:433-444, 2004
23. Walkley SU, Haskins ME, Shull RM: Alterations in neuron morphology in mucopolysaccharidosis type I: a Golgi study. Acta Neuropathol (Berl) 75:611-620, 1988
24. Walkley SU, Thrall MA, Haskins ME, Mitchell TW, Wenger DA, Brown DE, Dial S, Seim H: Abnormal neuronal metabolism and storage in mucopolysaccharidosis type VI (Maroteaux-Lamy) disease. Neuropathol Applied Neurobiol 31:536-544, 2005
25. Wu Y-P, Proia RL: Deletion of macrophage-inflammatory protein 1α retards neurodegeneration in Sandhoff disease mice. Proc Natl Acad Sci USA 101:8425-8430, 2004
26. M2 gangliosidoses. J Clin Invest 113:200-208, 2004
27. Yanagishita M: Cellular catabolism of heparan sulfate proteoglycans. Trends Glycosci Glycotechnol 10:57-63, 1998
28. Yogalingam G, Pollard T, Gliddon B, Jolly RD, Hopwood JJ: Identification of a mutation causing mucopolysaccharidosis type IIIA in New Zealand Huntaway dogs. Genomics 79:150-151, 2002
29. Zajchowski LD, Robbins SM: Lipid rafts and little caves. Eur J Biochem 269:737-752, 2002
30. Zervas M, Walkley SU: Ferret pyramidal cell dendritogenesis: changes in morphology and ganglioside expression during cortical development. J Comp Neurol 269:429-448, 1999
31. Zervas M, Dobrenis K, Walkley SU: Neurons in Nieman-Pick disease type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations. J Neuropathol Exp Neurol 60:49-64, 2001